Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover study of galactosidase in type IV galactosemia
jRCTs021200008Phase 2Completed
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in galactosemia (2 arms). Primary endpoint: Blood galactose levels at 2 or 3 hours after lactose loading. Started Mar 2020; status: completed.
02
Conditions
galactosemia
Beyond the preview
Go deeper on jRCTs021200008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021200008.